Scientists are investigating how regulatory T cells and gut health influence immune responses in conditions like cancer, allergies, and multiple sclerosis.

Researchers at the University of Zurich are studying the complex regulation of the immune system, specifically focusing on regulatory T cells (Tregs) that maintain balance in the body. By investigating how these cells act as 'brakes' and repair mechanisms, scientists aim to better understand autoimmune diseases, cancer, and allergies. The research also highlights the significant role the gut microbiome plays in immune function and the development of conditions such as multiple sclerosis.

The Role of Regulatory T Cells

Regulatory T cells (Tregs) act as balancing forces that prevent the immune system from attacking the body's own tissues. Immunologist Nicole Joller and her team are studying these 'brakes' to understand why they sometimes fail in cases of allergies or fail to stimulate an adequate response against tumors. Recent discoveries have identified 'switch' molecules that can activate or inhibit these cells, which could lead to targeted immunotherapies that reactivate immune defenses without paralyzing the entire system.

Gut Microbiome and Multiple Sclerosis

Research into multiple sclerosis (MS) by Roland Martin and Mireia Sospedra suggests a potential link between gut health and disease development. Approximately 80% of the body's immune cells reside in the gut, where an imbalance in the microbiome—potentially caused by low-fiber diets—can lead to inflammation. This inflammation may allow misdirected T cells to cross the blood-brain barrier and attack the myelin sheaths of nerve fibers, a hallmark of MS.